SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-035870
Filing Date
2024-11-20
Accepted
2024-11-20 16:37:14
Documents
2
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 2721
2 landenpoa.htm EX-24 11083
  Complete submission text file 0001437749-24-035870.txt   15405
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1, SUITE 300 AUSTIN TX 78731
Business Address
Landen Jaren (Reporting) CIK: 0002045287 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41905 | Film No.: 241480910